Lmb Technologie Initiates Strategic Growth Phase with Macopharma Merger
Deal News | Apr 22, 2025 | Baybg Bayerische Beteiligungsg
BayBG Bayerische Beteiligungsgesellschaft, alongside the Jentsch family (founders), has successfully exited its investment in Lmb Technologie GmbH by selling the company to French firm Macopharma GMPi group. This strategic acquisition is part of Macopharma's efforts to enhance its presence in European, American, and Middle Eastern markets. Lmb Technologie, a leader in medical technology for blood processing, has been known for its innovative devices, notably blood separators. BayBG identified Lmb's potential early on and invested back in 2013 to accelerate growth and prepare for succession. This relationship was further strengthened by a subsequent investment in 2020, facilitating technological advancements amid rising demand for blood separation devices. The founders of Lmb appreciate BayBG's support and are optimistic about further growth under Macopharma, a renowned industry player.
Sectors
- Medical Devices
- Private Equity
Geography
- Germany – Lmb Technologie GmbH is based in Schwaig, Germany, and BayBG Bayerische Beteiligungsgesellschaft is headquartered in Munich, Germany.
- France – Macopharma GMPi group, the acquiring company, is a French firm seeking to strengthen its market position through this acquisition.
Industry
- Medical Devices – Lmb Technologie GmbH specializes in developing and distributing innovative medical devices for blood donation, separation, and logistics.
- Private Equity – BayBG Bayerische Beteiligungsgesellschaft's involvement as an investor in Lmb Technologie highlights the private equity sector's role in supporting growth and succession planning for mid-sized companies.
Financials
- Not Disclosed – The purchase price for the acquisition of Lmb Technologie by Macopharma was not disclosed in the article.
- 382 million EUR – Total invested volume by BayBG in various mid-sized companies.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Lmb Technologie GmbH | Target Company | Company | A German company specializing in medical technology for blood processing, including blood donation, separation, and logistics. |
| BayBG Bayerische Beteiligungsgesellschaft | Private Equity Firm | Company | A major German private equity firm involved in investing and providing growth support for mid-sized companies. |
| Macopharma GMPi group | Acquirer | Company | A French company aiming to bolster its market presence in blood processing solutions across Europe, America, and the Middle East. |
| Jentsch Family | Selling Company/Founders | People | Founders of Lmb Technologie GmbH, involved in the company's sale to Macopharma. |